SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Puma Biotechnology Reports Third-Quarter 2026 Financial Results

Puma Biotechnology announced results for the quarter ended September 30, 2026. The supplied report excerpt contains no financial figures.

PBYI
SquawkNews Desk

Puma Biotechnology, Inc. (NASDAQ:PBYI), a biopharmaceutical company, announced financial results for the third quarter ended September 30, 2026. Unless otherwise stated, all comparisons are for the third quarter of 2026 compared to the third quarter of 2025.Product revenue, net consists entirely of…

Related stories

Mattel Lowers Full-Year Sales and Earnings Guidance After Mixed Results Mattel reported mixed quarterly results and lowered its full-year guidance for sales and earnings. Adjusted earnings were $1.30 a share, above 94 cents a share. The company also na M impact | EQUITY | Nov 05, 2026, 10:36 PM UTC Funko Reports Third-Quarter 2026 Financial Results Funko reported its third-quarter results and reaffirmed previously issued full-year net sales and adjusted EBITDA guidance. M impact | EQUITY | Nov 05, 2026, 10:34 PM UTC VAALCO Energy Reports Q3 2026 Loss, Higher Production and Updated Guidance VAALCO reported a $39.8 million net loss, or $0.38 per diluted share, primarily attributed to non-cash derivative losses. Adjusted EBITDAX rose 30% to $71.1 million, and working-in M impact | EQUITY | Nov 05, 2026, 10:34 PM UTC IBEX Reports Fiscal Q1 Revenue Growth and Raises Full-Year Guidance Revenue rose 16% year over year to $175.2 million, while net income increased to $14.8 million from $12.0 million. IBEX raised its full-year revenue and adjusted EBITDA guidance. M impact | EQUITY | Nov 05, 2026, 10:34 PM UTC Kingstone Reports Record Quarterly Profit, Updates 2026 Guidance Kingstone reported third-quarter net income up 62% to $17.6 million, or $1.19 per diluted share. Net premiums earned rose 30% to $62.4 million, and its GAAP net combined ratio impr M impact | EQUITY | Nov 05, 2026, 10:34 PM UTC TrueBlue Reports Q3 Revenue Growth and Provides Q4 Outlook TrueBlue reported Q3 2026 revenue of $520.74 million, up 20.7% year over year, and net income of $9.25 million, or $0.28 per diluted share, versus a year-ago net loss. It forecast M impact | EQUITY | Nov 05, 2026, 10:34 PM UTC